Collaborating once again with iS Clinical, these industry-leading brands will further educate and inspire on the combined use of lasers and cosmeceuticals for improved patient outcomes

Hologic’s CynoSure UK division, a leading laser manufacturer has announced its upcoming second symposium as part of their Aesthetic Exchange educational platform, once again in collaboration with leading cosmeceutical brand iS Clinical.

On 22 and 23 November 2019, the event titled “Topicals and Lasers; Maximising outcome and income” will provide practitioners with the opportunity to attend several in depth seminars, discussions and live demonstrations spanning both face and body indications, led by a stellar panel of industry authorities, internationally-renowned expert speakers and clinical trainers at the King’s Fund, London.

The event will be led by two special guests, Dr Dianne Quibell (world-renowned Cosmetic Laser Surgeon, Aesthetic Physician, and VP of the American Board of Laser Surgery) and Dr Charlene DeHaven (Clinical Director of iS Clinical) who will be joining from the US to share their experience in light-based technology and epigenetics, and how best to combine the power of lasers and cosmeceuticals for superior patient outcomes.

Across the two days, the sessions will discuss pigmentation, scarring and vascular issues, through to laser hair and tattoo removal and body contouring, demonstrating the combined uses of iS Clinical’s active formulations and CynoSure’s laser technologies.

The two brands first joined forces in June of this year, with an expert-led educational event illustrating how cosmeceutical skincare and laser rejuvenation technologies can work synergistically for enhanced patient outcomes, alongside providing a robust commercial strategy and support for clinics.


Evolution of a patient & practice journey; Integrating Topicals & Lasers
November 22 & 23
The King’s Fund, Cavendish Square, LondonTickets available via EventBrite

About Hologic

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit

Cynosure UK Ltd is a wholly owned subsidiary of Hologic, Inc.